{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,16]],"date-time":"2026-07-16T08:06:14Z","timestamp":1784189174203,"version":"3.55.0"},"reference-count":43,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2026,5,23]],"date-time":"2026-05-23T00:00:00Z","timestamp":1779494400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"},{"start":{"date-parts":[[2026,7,16]],"date-time":"2026-07-16T00:00:00Z","timestamp":1784160000000},"content-version":"vor","delay-in-days":54,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["World J Surg Onc"],"DOI":"10.1186\/s12957-026-04384-6","type":"journal-article","created":{"date-parts":[[2026,5,23]],"date-time":"2026-05-23T03:06:53Z","timestamp":1779505613000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":0,"title":["MiR-4725-3p acts as an oncogene and prognostic biomarker in hepatocellular carcinoma"],"prefix":"10.1186","volume":"24","author":[{"given":"Xiumin","family":"Zhao","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zhenhong","family":"Chang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jinmin","family":"Su","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jiaoling","family":"Gu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zhizhong","family":"Lu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Peng","family":"Dai","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2026,5,23]]},"reference":[{"key":"4384_CR1","doi-asserted-by":"publisher","first-page":"1170207","DOI":"10.3389\/fimmu.2023.1170207","volume":"14","author":"C Shen","year":"2023","unstructured":"Shen C, Li M, Duan Y, Jiang X, Hou X, Xue F, et al. HDAC inhibitors enhance the anti-tumor effect of immunotherapies in hepatocellular carcinoma. Front Immunol. 2023;14:1170207.","journal-title":"Front Immunol"},{"key":"4384_CR2","doi-asserted-by":"crossref","unstructured":"Lai M, Liu Q, Chen W, Qi X, Yang J, Jiang L et al. Identification and Validation of Two Heterogeneous Molecular Subtypes and a Prognosis Predictive Model for Hepatocellular Carcinoma Based on Pyroptosis. Oxid Med Cell Longev. 2022;2022:8346816.","DOI":"10.1155\/2022\/8346816"},{"key":"4384_CR3","doi-asserted-by":"publisher","first-page":"2453","DOI":"10.2147\/JHC.S492420","volume":"11","author":"J Bei","year":"2024","unstructured":"Bei J, Sun Z, Fu R, Huang X, Huang J, Luo Y, et al. PPIH Expression Correlates with Tumor Aggressiveness and Immune Dysregulation in Hepatocellular Carcinoma. J hepatocellular carcinoma. 2024;11:2453\u201370.","journal-title":"J hepatocellular carcinoma"},{"issue":"7","key":"4384_CR4","doi-asserted-by":"publisher","first-page":"929","DOI":"10.2174\/1874467215666220103111009","volume":"15","author":"S Altaf","year":"2022","unstructured":"Altaf S, Saleem F, Sher AA, Ali A. Potential Therapeutic Strategies to Combat HCC. Curr Mol Pharmacol. 2022;15(7):929\u201342.","journal-title":"Curr Mol Pharmacol"},{"issue":"2","key":"4384_CR5","doi-asserted-by":"publisher","first-page":"84","DOI":"10.2174\/1566523220666200628014530","volume":"20","author":"CH Zhang","year":"2020","unstructured":"Zhang CH, Li M, Lin YP, Gao Q. Systemic Therapy for Hepatocellular Carcinoma: Advances and Hopes. Curr Gene Ther. 2020;20(2):84\u201399.","journal-title":"Curr Gene Ther"},{"issue":"10","key":"4384_CR6","doi-asserted-by":"publisher","first-page":"670","DOI":"10.1038\/s41575-022-00620-y","volume":"19","author":"P Johnson","year":"2022","unstructured":"Johnson P, Zhou Q, Dao DY, Lo YMD. Circulating biomarkers in the diagnosis and management of hepatocellular carcinoma. Nat reviews Gastroenterol Hepatol. 2022;19(10):670\u201381.","journal-title":"Nat reviews Gastroenterol Hepatol"},{"key":"4384_CR7","doi-asserted-by":"publisher","first-page":"877","DOI":"10.2147\/CMAR.S186561","volume":"11","author":"H Li","year":"2019","unstructured":"Li H, Zhao X, Li C, Sheng C, Bai Z. Integrated analysis of lncRNA-associated ceRNA network reveals potential biomarkers for the prognosis of hepatitis B virus-related hepatocellular carcinoma. Cancer Manage Res. 2019;11:877\u201397.","journal-title":"Cancer Manage Res"},{"issue":"7","key":"4384_CR8","doi-asserted-by":"publisher","first-page":"1327","DOI":"10.1016\/j.cell.2017.05.046","volume":"169","author":"A David","year":"2017","unstructured":"David A, Wheeler, Roberts LR. Comprehensive and Integrative Genomic Characterization of Hepatocellular Carcinoma. Cell. 2017;169(7):1327\u2013e4123.","journal-title":"Cell"},{"issue":"1","key":"4384_CR9","doi-asserted-by":"publisher","first-page":"147","DOI":"10.1186\/s12943-019-1086-z","volume":"18","author":"L Wei","year":"2019","unstructured":"Wei L, Wang X, Lv L, Liu J, Xing H, Song Y, et al. The emerging role of microRNAs and long noncoding RNAs in drug resistance of hepatocellular carcinoma. Mol Cancer. 2019;18(1):147.","journal-title":"Mol Cancer"},{"issue":"3","key":"4384_CR10","doi-asserted-by":"publisher","first-page":"182","DOI":"10.2174\/1874467212666191113130312","volume":"13","author":"S Xiang","year":"2020","unstructured":"Xiang S, Shao X, Cao J, Yang B, He Q, Ying M. FAT10: Function and Relationship with Cancer. Curr Mol Pharmacol. 2020;13(3):182\u201391.","journal-title":"Curr Mol Pharmacol"},{"key":"4384_CR11","unstructured":"Cao Z, Zeng L, Wang Z, Zhou Y, Qian K. Role of miR-5010-3p in predicting the prognosis of hepatocellular carcinoma. J Cent South Univ. (Med Sci). 2023;48(9):1281\u201395."},{"issue":"8","key":"4384_CR12","doi-asserted-by":"publisher","first-page":"841","DOI":"10.1007\/s12094-015-1447-z","volume":"18","author":"L Yang","year":"2016","unstructured":"Yang L, Xu Q, Xie H, Gu G, Jiang J. Expression of serum miR-218 in hepatocellular carcinoma and its prognostic significance. Clin translational oncology: official publication Federation Span Oncol Soc Natl Cancer Inst Mexico. 2016;18(8):841\u20137.","journal-title":"Clin translational oncology: official publication Federation Span Oncol Soc Natl Cancer Inst Mexico"},{"issue":"16","key":"4384_CR13","doi-asserted-by":"publisher","first-page":"14657","DOI":"10.1007\/s00432-023-05257-1","volume":"149","author":"Y Chen","year":"2023","unstructured":"Chen Y, Xu H, Tang H, Li H, Zhang C, Jin S, et al. miR-9-5p expression is associated with vascular invasion and prognosis in hepatocellular carcinoma, and in vitro verification. J Cancer Res Clin Oncol. 2023;149(16):14657\u201371.","journal-title":"J Cancer Res Clin Oncol"},{"issue":"3","key":"4384_CR14","doi-asserted-by":"publisher","first-page":"269","DOI":"10.1111\/jnc.14459","volume":"146","author":"KH Ho","year":"2018","unstructured":"Ho KH, Chang CK, Chen PH, Wang YJ, Chang WC, Chen KC. miR-4725-3p targeting stromal interacting molecule 1 signaling is involved in xanthohumol inhibition of glioma cell invasion. J Neurochem. 2018;146(3):269\u201388.","journal-title":"J Neurochem"},{"key":"4384_CR15","doi-asserted-by":"publisher","first-page":"111965","DOI":"10.1016\/j.cellsig.2025.111965","volume":"134","author":"C Xie","year":"2025","unstructured":"Xie C, Zhou G, Chen T, Li Q, Yuan H, Xu Y, et al. Circ_0084927 promotes progression of intrahepatic cholangiocarcinoma by sponging miR-4725-5p to activate the PDPK1\/AKT\/mTOR signaling pathway. Cell Signal. 2025;134:111965.","journal-title":"Cell Signal"},{"key":"4384_CR16","doi-asserted-by":"crossref","unstructured":"Saeki C, Matsuzaki J, Kuroda M, Fujita K, Ichikawa M, Takizawa S et al. Identification of circulating microRNAs as potential biomarkers for hepatic necroinflammation in patients with autoimmune hepatitis. BMJ open Gastroenterol. 2022;9(1):e000879.","DOI":"10.1136\/bmjgast-2022-000879"},{"key":"4384_CR17","doi-asserted-by":"publisher","first-page":"e11910","DOI":"10.7717\/peerj.11910","volume":"9","author":"Y Tai","year":"2021","unstructured":"Tai Y, Zhao C, Gao J, Lan T, Tong H. Identification of miRNA-target gene regulatory networks in liver fibrosis based on bioinformatics analysis. PeerJ. 2021;9:e11910.","journal-title":"PeerJ"},{"key":"4384_CR18","doi-asserted-by":"crossref","unstructured":"Rokavec M, Hermeking H, miRTARGET: An integrated web tool for the identification of microRNA targets with potential therapeutic or prognostic value in cancer. New York: Neoplasia. 2025;67:101202.","DOI":"10.1016\/j.neo.2025.101202"},{"key":"4384_CR19","doi-asserted-by":"crossref","unstructured":"Kim NJ, Li M, Vutien P, Mecham B, Borgerding J, Swarts K et al. Changes in Liver Disease Etiology Support a Lower Alpha-Fetoprotein Threshold for Hepatocellular Carcinoma Screening. Gastroenterology. 2026;170(3):606\u201318.","DOI":"10.1053\/j.gastro.2025.08.021"},{"key":"4384_CR20","doi-asserted-by":"crossref","unstructured":"Zhang S, Xu H, Li M, Yuan G, Nie J, Zhang Q et al. An etiology-stratified single-cell atlas identifies FABP4 as a prognostic marker for MASLD-related HCC. J Hepatol. 2026;84(5):920\u201332.","DOI":"10.1016\/j.jhep.2025.10.026"},{"issue":"13","key":"4384_CR21","doi-asserted-by":"publisher","first-page":"4072","DOI":"10.7150\/jca.95339","volume":"15","author":"J Li","year":"2024","unstructured":"Li J, Wu Z, Pan Y, Chen Y, Chu J, Cong Y, et al. GNL3L exhibits pro-tumor activities via NF-\u03baB pathway as a poor prognostic factor in acute myeloid leukemia. J Cancer. 2024;15(13):4072\u201380.","journal-title":"J Cancer"},{"issue":"1","key":"4384_CR22","doi-asserted-by":"publisher","first-page":"29500","DOI":"10.1038\/s41598-025-15309-w","volume":"15","author":"K Wang","year":"2025","unstructured":"Wang K, Li K, Zhang Z, Zeng X, Wu Z, Zhang B, et al. Combined preoperative platelet-albumin ratio and cancer inflammation prognostic index predicts prognosis in colorectal cancer: a retrospective study. Sci Rep. 2025;15(1):29500.","journal-title":"Sci Rep"},{"issue":"1","key":"4384_CR23","doi-asserted-by":"publisher","first-page":"1822","DOI":"10.1186\/s12885-025-15165-x","volume":"25","author":"K Li","year":"2025","unstructured":"Li K, Zhang R, Zhang J, Zhang Z, Wang K, Lu Y, et al. The prognostic role of inflammation-based hematologic markers in stage I-III colorectal cancer: a retrospective analysis. BMC Cancer. 2025;25(1):1822.","journal-title":"BMC Cancer"},{"issue":"1","key":"4384_CR24","doi-asserted-by":"publisher","first-page":"23","DOI":"10.5152\/alphapsychiatry.2024.231216","volume":"25","author":"H Wei","year":"2024","unstructured":"Wei H, Kong L, Zhu X, Chen S, Zhang L, Niu W. The Correlation Between Peripheral Blood Micro-Ribonucleic Acid Expression Level and Personality Disorder in Patients with Schizophrenia. Alpha psychiatry. 2024;25(1):23\u20139.","journal-title":"Alpha psychiatry"},{"key":"4384_CR25","doi-asserted-by":"crossref","unstructured":"Jung JH, Shin EA, Kim JH, Sim DY, Lee H, Park JE et al. NEDD9 Inhibition by miR-25-5p Activation Is Critically Involved in Co-Treatment of Melatonin- and Pterostilbene-Induced Apoptosis in Colorectal Cancer Cells. Cancers (Basel). 2019;11(11):1684.","DOI":"10.3390\/cancers11111684"},{"key":"4384_CR26","doi-asserted-by":"crossref","unstructured":"Dong Y, Ding YH, Yang X, Song XH, Lei XT, Tang YN et al. EIF4A3\/circPTGR1\/miR-4725-5p positive- feedback loop promotes colorectal cancer progression via FAK\/AKT signaling pathway. Mol Cancer. 2026;25(1):28.","DOI":"10.1186\/s12943-025-02537-x"},{"key":"4384_CR27","doi-asserted-by":"publisher","first-page":"e6668","DOI":"10.7717\/peerj.6668","volume":"7","author":"M Shao","year":"2019","unstructured":"Shao M, Li W. Transcriptional factor regulation network and competitive endogenous RNA (ceRNA) network determining response of esophageal squamous cell carcinomas to neoadjuvant chemoradiotherapy. PeerJ. 2019;7:e6668.","journal-title":"PeerJ"},{"key":"4384_CR28","doi-asserted-by":"crossref","unstructured":"Paerhati P, Liu J, Jin Z, Jako\u0161 T, Zhu S, Qian L et al. Advancements in Activating Transcription Factor 5 Function in Regulating Cell Stress and Survival. Int J Mol Sci. 2022;23(13):7129.","DOI":"10.3390\/ijms23137129"},{"issue":"8","key":"4384_CR29","doi-asserted-by":"publisher","first-page":"2939","DOI":"10.1074\/jbc.RA117.001151","volume":"293","author":"Y Yuan","year":"2018","unstructured":"Yuan Y, Gaither K, Kim E, Liu E, Hu M, Lengel K, et al. SUMO2\/3 modification of activating transcription factor 5 (ATF5) controls its dynamic translocation at the centrosome. J Biol Chem. 2018;293(8):2939\u201348.","journal-title":"J Biol Chem"},{"key":"4384_CR30","doi-asserted-by":"publisher","first-page":"131","DOI":"10.2147\/CMAR.S496925","volume":"17","author":"F Shi","year":"2025","unstructured":"Shi F, Wei Y, Huang Y, Yao D. Activating Transcription Factor 5 Promotes Tumorigenic Capability in Cervical Cancer Through the Wnt\/\u03b2-Catenin Signaling Pathway. Cancer Manage Res. 2025;17:131\u201343.","journal-title":"Cancer Manage Res"},{"key":"4384_CR31","doi-asserted-by":"publisher","first-page":"8673","DOI":"10.2147\/OTT.S176549","volume":"11","author":"J Feldheim","year":"2018","unstructured":"Feldheim J, Kessler AF, Schmitt D, Wilczek L, Linsenmann T, Dahlmann M, et al. Expression of activating transcription factor 5 (ATF5) is increased in astrocytomas of different WHO grades and correlates with survival of glioblastoma patients. Onco Targets Ther. 2018;11:8673\u201384.","journal-title":"Onco Targets Ther"},{"issue":"1","key":"4384_CR32","doi-asserted-by":"publisher","first-page":"660","DOI":"10.1186\/s12935-021-02315-x","volume":"21","author":"J Zhou","year":"2021","unstructured":"Zhou J, Tian H, Zhi X, Xiao Z, Chen T, Yuan H, et al. Activating transcription factor 5 (ATF5) promotes tumorigenic capability and activates the Wnt\/b-catenin pathway in bladder cancer. Cancer Cell Int. 2021;21(1):660.","journal-title":"Cancer Cell Int"},{"key":"4384_CR33","doi-asserted-by":"publisher","first-page":"173","DOI":"10.3389\/fendo.2017.00173","volume":"8","author":"S Ben-Shmuel","year":"2017","unstructured":"Ben-Shmuel S, Rashed R, Rostoker R, Isakov E, Shen-Orr Z, LeRoith D. Activating Transcription Factor-5 Knockdown Reduces Aggressiveness of Mammary Tumor Cells and Attenuates Mammary Tumor Growth. Front Endocrinol. 2017;8:173.","journal-title":"Front Endocrinol"},{"issue":"23","key":"4384_CR34","doi-asserted-by":"publisher","first-page":"19599","DOI":"10.1074\/jbc.M112.363622","volume":"287","author":"X Liu","year":"2012","unstructured":"Liu X, Liu D, Qian D, Dai J, An Y, Jiang S, et al. Nucleophosmin (NPM1\/B23) interacts with activating transcription factor 5 (ATF5) protein and promotes proteasome- and caspase-dependent ATF5 degradation in hepatocellular carcinoma cells. J Biol Chem. 2012;287(23):19599\u2013609.","journal-title":"J Biol Chem"},{"issue":"16","key":"4384_CR35","doi-asserted-by":"publisher","first-page":"6743","DOI":"10.1158\/0008-5472.CAN-07-6469","volume":"68","author":"JW Gho","year":"2008","unstructured":"Gho JW, Ip WK, Chan KY, Law PT, Lai PB, Wong N. Re-expression of transcription factor ATF5 in hepatocellular carcinoma induces G2-M arrest. Cancer Res. 2008;68(16):6743\u201351.","journal-title":"Cancer Res"},{"issue":"11","key":"4384_CR36","doi-asserted-by":"publisher","first-page":"269","DOI":"10.1007\/s12032-014-0269-0","volume":"31","author":"Y Wu","year":"2014","unstructured":"Wu Y, Wu B, Chen R, Zheng Y, Huang Z. High ATF5 expression is a favorable prognostic indicator in patients with hepatocellular carcinoma after hepatectomy. Med Oncol (Northwood Lond Engl). 2014;31(11):269.","journal-title":"Med Oncol (Northwood Lond Engl)"},{"issue":"1","key":"4384_CR37","doi-asserted-by":"publisher","first-page":"134","DOI":"10.1167\/iovs.18-24878","volume":"60","author":"AG Hindle","year":"2019","unstructured":"Hindle AG, Thoonen R, Jasien JV, Grange RMH, Amin K, Wise J, et al. Identification of Candidate miRNA Biomarkers for Glaucoma. Investig Ophthalmol Vis Sci. 2019;60(1):134\u201346.","journal-title":"Investig Ophthalmol Vis Sci"},{"issue":"4","key":"4384_CR38","doi-asserted-by":"publisher","first-page":"3716","DOI":"10.18632\/aging.205554","volume":"16","author":"X Cheng","year":"2024","unstructured":"Cheng X, Wu C, Xu H, Zou R, Li T, Ye S. miR-557 inhibits hepatocellular carcinoma progression through Wnt\/\u03b2-catenin signaling pathway by targeting RAB10. Aging. 2024;16(4):3716\u201333.","journal-title":"Aging"},{"issue":"7","key":"4384_CR39","doi-asserted-by":"publisher","first-page":"1125","DOI":"10.3724\/abbs.2025038","volume":"57","author":"G Wang","year":"2025","unstructured":"Wang G, Yang Q, Han Y, Zhang Y, Pan W, Ma Z, et al. miR-32-5p suppresses the progression of hepatocellular carcinoma by regulating the GSK3\u03b2\/NF-\u03baB signaling. Acta Biochim Biophys Sin. 2025;57(7):1125\u201338.","journal-title":"Acta Biochim Biophys Sin"},{"issue":"3","key":"4384_CR40","doi-asserted-by":"publisher","first-page":"3759","DOI":"10.1007\/s12013-025-01752-z","volume":"83","author":"X Wang","year":"2025","unstructured":"Wang X, Li J, Nong J, Deng X, Chen Y, Han B, et al. MiR-518b Promotes the Tumorigenesis of Hepatocellular Carcinoma by Targeting EGR1 to Regulate PI3K\/AKT\/mTOR Signaling Pathway. Cell Biochem Biophys. 2025;83(3):3759\u201372.","journal-title":"Cell Biochem Biophys"},{"issue":"21","key":"4384_CR41","doi-asserted-by":"publisher","first-page":"e71317","DOI":"10.1002\/cam4.71317","volume":"14","author":"Y Chen","year":"2025","unstructured":"Chen Y, Bai M, Liu M, Zhang Z, Jiang C, Li K, et al. Metabolic Reprogramming in Lung Cancer: Hallmarks, Mechanisms, and Targeted Strategies to Overcome Immune Resistance. Cancer Med. 2025;14(21):e71317.","journal-title":"Cancer Med"},{"issue":"1","key":"4384_CR42","doi-asserted-by":"publisher","first-page":"315","DOI":"10.1007\/s12672-026-04464-9","volume":"17","author":"Z Diao","year":"2026","unstructured":"Diao Z, Chen Y, Guo W. Pan-cancer multi-dimensional characterization and biological significance of cholesterol 25-hydroxylase (CH25H). Discover Oncol. 2026;17(1):315.","journal-title":"Discover Oncol"},{"key":"4384_CR43","doi-asserted-by":"publisher","first-page":"103094","DOI":"10.1016\/j.tice.2025.103094","volume":"97","author":"J Jiang","year":"2025","unstructured":"Jiang J, Li X, Zhang H, Liu W, Hu C, Hu Z. ATF5 inhibits autophagy and the Wnt\/\u03b2-catenin pathway by upregulating mTOR to suppress the stemness of liver cancer stem cells. Tissue Cell. 2025;97:103094.","journal-title":"Tissue Cell"}],"container-title":["World Journal of Surgical Oncology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s12957-026-04384-6","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12957-026-04384-6.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12957-026-04384-6.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,7,16]],"date-time":"2026-07-16T07:31:45Z","timestamp":1784187105000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1186\/s12957-026-04384-6"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,5,23]]},"references-count":43,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2026,12]]}},"alternative-id":["4384"],"URL":"https:\/\/doi.org\/10.1186\/s12957-026-04384-6","relation":{},"ISSN":["1477-7819"],"issn-type":[{"value":"1477-7819","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,5,23]]},"assertion":[{"value":"3 February 2026","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"2 May 2026","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"23 May 2026","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"The study protocol was approved by The Ethics Committee of Jiaozuo People\u2019s Hospital and followed the principles outlined in the Declaration of Helsinki. In addition, informed consent has been obtained from the participants involved.","order":1,"name":"Ethics","label":"Ethics approval and consent to participate","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"Not applicable.","order":2,"name":"Ethics","label":"Consent for publication","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The authors declare no competing interests.","order":3,"name":"Ethics","label":"Competing interests","group":{"name":"EthicsHeading","label":"Declarations"}}],"article-number":"296"}}